Publications by authors named "Edward R Samuel"

Claim this Profile
V
Vacuum-assisted decellularization: an accelerated protocol to generate tissue-engineered human tracheal scaffolds.
Colin R Butler, Robert E Hynds, Claire Crowley, Kate H C Gowers, Leanne Partington, Edward R Samuel

Biomaterials· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-Stage Priming of Allogeneic Natural Killer Cells for the Treatment of Patients with Acute Myeloid Leukemia: A Phase I Trial.
Panagiotis D Kottaridis, Janet North, Maria Tsirogianni, Chloe Marden, Edward R Samuel

PLoS One· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the effector function of CMV-specific CTLs isolated using MHC-multimers from granulocyte-colony stimulating factor mobilized peripheral blood.
Lorea Beloki, Miriam Ciaurriz, Cristina Mansilla, Amaya Zabalza, Estela Perez-Valderrama, Edward R Samuel

J Transl Med· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CMV-specific T cell isolation from G-CSF mobilized peripheral blood: depletion of myeloid progenitors eliminates non-specific binding of MHC-multimers.
Lorea Beloki, Miriam Ciaurriz, Cristina Mansilla, Amaya Zabalza, Estela Perez-Valderrama, Edward R Samuel

J Transl Med· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Manufacturing of highly functional and specific T cells for adoptive immunotherapy against virus from granulocyte colony-stimulating factor-mobilized donors.
Lorea Beloki, Natalia Ramírez, Eduardo Olavarría, Edward R Samuel, Mark W Lowdell

Cytotherapy· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation of highly suppressive CD25+FoxP3+ T regulatory cells from G-CSF-mobilized donors with retention of cytotoxic anti-viral CTLs: application for multi-functional immunotherapy post stem cell transplantation.
Edward R Samuel, Lorea Beloki, Katy Newton, Stephen Mackinnon, Mark W Lowdell

PLoS One· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful isolation and expansion of CMV-reactive T cells from G-CSF mobilized donors that retain a strong cytotoxic effector function.
Edward R Samuel, Katy Newton, Stephen Mackinnon, Mark W Lowdell

Br J Haematol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The JAK3-selective inhibitor PF-956980 reverses the resistance to cytotoxic agents induced by interleukin-4 treatment of chronic lymphocytic leukemia cells: potential for reversal of cytoprotection by the microenvironment.
Andrew J Steele, Archibald G Prentice, Kate Cwynarski, A Victor Hoffbrand, Stephen M Hart, Edward R Samuel

Blood· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-Phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells.
Andrew J Steele, Archibald G Prentice, A Victor Hoffbrand, Birunthini C Yogashangary, Stephen M Hart, Edward R Samuel

Blood· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis